NYSE$SEM
Select Medical Holdings Corporation · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Select Medical's Q1 2024 performance was marked by revenue growth and increased profitability.
Select Medical Holdings Corporation reported a 7.4% increase in revenue to $1,788.8 million for the first quarter ended March 31, 2024, compared to $1,665.0 million for the same quarter, prior year. Net income increased 37.4% to $117.2 million, and earnings per share increased 33.9% to $0.75.
- Revenue increased by 7.4% to $1,788.8 million compared to the same quarter last year.
- Net income increased by 37.4% to $117.2 million compared to the same quarter last year.
- Earnings per share increased by 33.9% to $0.75 compared to the same quarter last year.
- Adjusted EBITDA increased by 22.4% to $261.9 million compared to the same quarter last year.
Headline financials
Revenue & EPS history
Select Medical · Revenue · Quarterly
$1.79B
Revenue by segment
Select Medical · $1.1B total across 3 segments · Q3 2023
- Critical Illness Recovery$564M+7.4%51.1%
- Outpatient Rehabilitation$292M+2.4%26.5%
- Rehabilitation Hospital$247M+7.7%22.4%
Forward guidance
Select Medical is reaffirming its 2024 business outlook for revenue and adjusting its 2024 business outlook for Adjusted EBITDA and fully diluted earnings per share. Select Medical expects revenue to be in the range of $6.9 billion to $7.1 billion, Adjusted EBITDA to be in the range of $845 million to $885 million, fully diluted earnings per share to be in the range of $1.95 to $2.19 and adjusted earnings per share to be in the range of $1.96 to $2.20.
Tailwinds
- Revenue expected to be in the range of $6.9 billion to $7.1 billion.
- Adjusted EBITDA expected to be in the range of $845 million to $885 million.
- Fully diluted earnings per share expected to be in the range of $1.95 to $2.19.
- Adjusted earnings per share expected to be in the range of $1.96 to $2.20.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q1 2024
-0.3%
Avg return
Earnings day
+0.1%
Avg return
5 days after
+0.5%
Avg return
30 days after
49%
32 / 65 earnings
Positive
+18.8%
Q3 2018
Best reaction
-22.2%
Q1 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.2% | +0.1% | +0.7% | |
| Q4 2025 | -6.5% | -7.3% | +1.1% | |
| Q3 2025 | -5.8% | -5.1% | +9.1% | |
| Q1 2025 | -22.2% | -17.7% | -16.2% | |
| Q4 2024 | -7.2% | -2.9% | -13.1% | |
| Q3 2024 | +9.4% | +13.3% | +19.3% | |
| Q2 2024 | -14.0% | -17.2% | -9.3% | |
| Q1 2024 | +12.3% | +17.0% | +23.5% | |
| Q4 2023 | +6.7% | +4.6% | +7.7% | |
| Q3 2023 | -1.2% | -2.7% | +3.9% | |
| Q2 2023 | -1.3% | -2.5% | -4.3% | |
| Q1 2023 | +4.8% | -0.8% | -2.8% | |
| Q4 2022 | -7.8% | -9.1% | -17.6% | |
| Q3 2022 | -6.5% | -10.9% | +0.9% | |
| Q2 2022 | -4.1% | -11.1% | -14.7% | |
| Q1 2022 | +0.9% | -4.2% | +10.6% | |
| Q4 2021 | +1.1% | +2.2% | +3.5% | |
| Q3 2021 | +2.4% | -0.9% | -18.4% | |
| Q2 2021 | -3.3% | -6.9% | -7.7% | |
| Q1 2021 | -2.5% | -3.1% | +4.9% | |
| Q4 2020 | +10.5% | +16.9% | +20.5% | |
| Q3 2020 | -1.7% | +8.5% | +15.4% | |
| Q2 2020 | +13.1% | +14.7% | +21.2% | |
| Q1 2020 | -15.3% | -12.9% | -6.3% | |
| Q4 2019 | +8.9% | -0.1% | -55.6% | |
| Q3 2019 | +5.7% | +10.6% | +22.9% | |
| Q2 2019 | -5.8% | -5.8% | -3.1% | |
| Q1 2019 | +1.7% | +3.0% | -1.3% | |
| Q4 2018 | +0.1% | -4.8% | -10.1% | |
| Q3 2018 | +18.8% | +21.2% | +16.9% | |
| Q2 2018 | -5.0% | -7.5% | -6.6% | |
| Q1 2018 | -4.4% | -3.5% | -2.9% | |
| Q4 2017 | +11.2% | +11.4% | +7.8% | |
| Q3 2017 | -7.8% | -9.4% | -6.5% | |
| Q2 2017 | +8.6% | +12.7% | +18.7% | |
| Q1 2017 | +5.9% | +1.1% | +3.7% | |
| Q4 2016 | +9.6% | +11.6% | -3.1% | |
| Q3 2016 | -8.2% | -6.1% | -1.2% | |
| Q2 2016 | +10.6% | +6.3% | +9.3% | |
| Q1 2016 | -4.5% | — | — | |
| Q4 2015 | +10.9% | — | — | |
| Q3 2015 | +5.0% | — | — | |
| Q2 2015 | +0.1% | — | — | |
| Q1 2015 | +0.0% | — | — | |
| Q4 2014 | -5.2% | — | — | |
| Q3 2014 | +11.3% | — | — | |
| Q2 2014 | -12.4% | — | — | |
| Q1 2014 | +0.5% | — | — | |
| Q4 2013 | +1.7% | — | — | |
| Q3 2013 | +1.1% | — | — | |
| Q2 2013 | +1.3% | — | — | |
| Q1 2013 | -2.5% | — | — | |
| Q4 2012 | +4.0% | — | — | |
| Q3 2012 | +10.0% | — | — | |
| Q2 2012 | +9.1% | — | — | |
| Q1 2011 | -3.2% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q4 2009 | -0.4% | — | — | |
| Q4 2011 | -0.4% | — | — | |
| Q3 2010 | -2.4% | — | — | |
| Q3 2011 | -2.4% | — | — | |
| Q4 2010 | -15.8% | — | — | |
| Q2 2010 | -15.8% | — | — | |
| Q2 2011 | -15.8% | — | — | |
| Q1 2010 | -7.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro